<DOC>
	<DOC>NCT00881608</DOC>
	<brief_summary>The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able induce menstruation.</brief_summary>
	<brief_title>Study to Evaluate Menses Induction in Women Administered Proellex</brief_title>
	<detailed_description>The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able to suppress endogenous progesterone in women. It is believed that giving Proellex in the early/mid-luteal phase of the cycle will suppress the effects of endogenous progesterone triggering the end of the cycle and inducing menstruation as happens naturally</detailed_description>
	<mesh_term>Amenorrhea</mesh_term>
	<criteria>Clinical laboratory tests within normal ranges A normal menstrual period of 2630 days Desiring not to become pregnant Agreeing to use a double barrier method of birth control for the duration of the trial Postmenopausal status Aamenorrhea or dysfunctional uterine bleeding Subjects demonstrating any clinically significant medical condition rendering the subjects infertile or marginally fertile Subjects with a Body Mass Index (BMI) below 18 or over 39</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Menstruation</keyword>
</DOC>